The effectiveness of intraoperative photodynamic therapy in the complex treatment of stage III and IV nephroblastoma in children
https://doi.org/10.24931/2413-9432-2025-14-4-34-42
Abstract
Nowadays, the problem of malignant neoplasms management remains a priority task. To achieve further progress in cancer treatment, it is necessary to focus on existing but still undervalued methods. One of these approaches is photodynamic therapy (PDT), which can be used in combination with surgery as well as with other antitumor drugs without any risk of inducing cross-resistance. Being miner invasive and selective in tumor targeting, and having no risk of complications, the technique is attractive for application in oncologic pediatrics as an innovation capable of expanding the range of therapeutic techniques. The aim of the study was to investigate the effectiveness of intraoperative photodynamic therapy in children with stage III–IV nephroblastoma. The study included 66 patients aged 0–11 years with stage III and IV nephroblastoma. The patients of the control group (35 children) underwent surgical treatment in combination with chemotherapy and radiation therapy according to the SIOP protocol. The patients of the main group (31 children) underwent therapy according to the SIOP protocol, but in combination with intraoperative PDT. The 5-year survival rate in the main group was 90.3%, in the control group – 71.4% (p = 0.05). The recurrence rate in the main group was 9.7%, in the control group – 11.4%. Thus, high therapeutic efficacy of PDT during intraoperative irradiation of the tumor bed after its removal has been demonstrated. The technique contributes to the increased survival rate of patients with retroperitoneal tumors, which is a promising method to be used in pediatric oncological practice.
About the Authors
N. M. RostovtsevRussian Federation
Chelyabinsk
V. G. Polyakov
Russian Federation
Moscow
N. E. Kuzmina
Russian Federation
Chelyabinsk
E. A. Neizvestnykh
Russian Federation
Chelyabinsk
A. V. Kuzmina
Russian Federation
Chelyabinsk
References
1. Rykov M.Yu., Baibarina E.N., Chumakova O.V., Polyakov V.G. Epidemiology of cancer in children in the Russian Federation: analysis of key indicators and ways to overcome the defects of statistical data. Onkopediatria, 2017, vol. 4, no. 3, pp. 159–176. (In Russ.) doi: 10.15690/onco.v4i3.1747.
2. Rykov M.Yu., Manerova O.A., Turabov I.A., Kozlov V.V., Reshetnikov V.A. The role of the pediatrician in the early diagnosis of malignant neoplasms in children. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics), 2020, vol. 65, no. 1, pp. 94–99. (In Russ.) doi: 10.21508/1027-4065-2020-65-1-94-99.
3. Graf N., Rübe C., Gessler M. Kidney tumors. In: Gadner H., Gaedicke G., Niemeyer C., Ritter J. (eds.). Pediatric hematology and oncology. Berlin, Heidelberg: Springer-Verlag; 2006, pp. 847–864. (In German.) doi: 10.1007/3-540-29036-2.
4. Illade L., Hernandez-Marques C., Cormenzana M., Lassaletta Á., Andión Catalán M., Ruano D., et al. Wilms' tumour: A review of 15 years recent experience. An. Pediatr. (Engl. Ed), 2018, vol. 88, no. 3, pp. 140–149. (In Spanish.) doi: 10.1016/j.anpedi.2017.03.019.
5. Kim S., Chung D.H. Pediatric solid malignancies: neuroblastoma and Wilms' tumor. Surg. Clin. North Am, 2006, vol. 86, no. 2, pp. 469–487, xi. doi: 10.1016/j.suc.2005.12.008.
6. Miniati D., Gay A.N., Parks K.V., Naik-Mathuria B.J., Hicks J., Nuchtern J.G., et al. Imaging accuracy and incidence of Wilms' and non-Wilms' renal tumors in children. J. Pediatr. Surg, 2008, vol. 43, no. 7, pp. 1301–1307. doi: 10.1016/j.jpedsurg.2008.02.077.
7. Rykov M.Yu., Polyakov V.G. Clinical manifestations and diagnosis of malignant neoplasms in children: what do pediatricians need to know? Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics), 2017, vol. 62, no. 5, pp. 69–79. (In Russ.) doi: 10.21508/1027-4065-2017-62-5-69-79.
8. Fedorova D.V. The differential diagnosis of neuroblastoma and Wilms' tumor: a clinical observation and review of the literature. Russian Journal of Pediatric Hematology and Oncology, 2015, vol. 2, no. 4, pp. 91–97. (In Russ.) doi: 10.17650/2311-1267-2015-2-4-91-97.
9. Meyer J.S., Harty M.P., Khademian Z. Imaging of neuroblastoma and Wilms' tumor. Magn. Reson. Imaging Clin. N. Am, 2002, vol. 10, no. 2, pp. 275–302. doi: 10.1016/s1064-9689(01)00010-1.
10. Bacellar I.O., Tsubone T.M., Pavani C., Baptista M.S. Photodynamic efficiency: from molecular photochemistry to cell death. Int. J. Mol. Sci, 2015, vol. 16, no. 9, pp. 20523–20559. doi: 10.3390/ijms160920523.
11. Kessel D. Death pathways associated with photodynamic therapy. Med. Laser Appl, 2006, vol. 21, no. 4, pp. 219–224. doi: 10.1016/j.mla.2006.05.006.
12. Mroz P., Hashmi J.T., Huang Y.Y., Lange N., Hamblin M.R. Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev. Clin. Immunol, 2011, vol. 7, no. 1, pp. 75–91. doi: 10.1586/eci.10.81.
13. Filonenko E.V. Fluorescence diagnostics and photodynamic therapy in oncology. Science in Russia, 2012, no. 4, pp. 4–9. (In Russ.)
14. Filonenko E.V. Fluorescence diagnostics and photodynamic therapy: justification of applications and opportunities in oncology. Photodynamic therapy and photodyagnosis, 2014, vol. 3, no. 1, pp. 3–7. (In Russ.)
15. Filonenko E.V., Serova L.G. Photodynamic therapy in clinical practice. Biomedical Photonics, 2016, vol. 5, no. 2, pp. 26–37. (In Russ.)
16. Sokolov V.V., Filonenko E.V. Photodynamic therapy in patients with early central lung cancer. Photodynamic therapy and photodyagnosis, 2013, vol. 2, no. 4, pp. 3–6. (In Russ.)
17. Sokolov V.V., Filonenko E.V., Karpova E.S. Long-term palliative treatment of patient with signet ring cell gastric cancer using endoscopic photodynamic therapy. Photodynamic therapy and photodyagnosis, 2014, vol. 3, no. 3, pp. 34–36. (In Russ.)
18. Titova V.A. The role of photodynamic therapy in multimodality cancer treatment. Photodynamic therapy and photodyagnosis, 2012, vol. 1, no. 1, pp. 3–5. (In Russ.) doi: 10.24931/2413-9432-2012-1-1-3-5.
19. Chernyshev I.V., Altunin D.V., Samsonov Yu.V., Kallaev K.K. Photodynamic methods of diagnostics and treatment of prostate and kidney cancer: new possibilities. Experimental and clinical urology, 2011, no. 2–3, pp. 92–94. (In Russ.)
20. Filatova N.V., Sidorenko E.I., Filatov V.V., Ponomarev G.V., Muravyev M.V. The use of photodynamic therapy with Photoditazine for the treatment of corneal neovascularization in children and adolescents. Russian Journal of Biotherapy, 2012, vol. 11, no. 2, pp. 56. (In Russ.)
21. Kumar N., Warren C.B. Photodynamic therapy for dermatologic conditions in the pediatric population: a literature review. Photodermatol. Photoimmunol. Photomed, 2017, vol. 33, no. 3, pp. 125–134. doi: 10.1111/phpp.12296.
22. Schipmann S., Müther M., Stögbauer L., Zimmer S., Brokinkel B., Holling M., et al. Combination of ALA-induced fluorescenceguided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control. J Neurosurg, 2020, vol. 134, no. 2, pp. 426–436. doi: 10.3171/2019.11.JNS192443.
23. Schwake M., Nemes A., Dondrop J., Schroeteler J., Schipmann S., Senner V., et al. In-vitro use of 5-ALA for photodynamic therapy in pediatric brain tumors. Neurosurgery, 2018, vol. 83, no. 6, pp. 1328–1337. doi: 10.1093/neuros/nyy054.
24. da Silva Barbosa P., Duarte D.A., Leite M.F., de Sant' Anna G.R. Photodynamic therapy in pediatric dentistry. Case Rep. Dent, 2014, vol. 2014, pp. 217172. doi: 10.1155/2014/217172.
25. Mazurin A.V., Vorontsov I.M. Propaedeutics of children diseases. Moscow: Meditsina; 1985. 432 p.
26. Breslow N.E., Collins A.J., Ritchey M.L., Grigoriev Y.A., Peterson S.M., Green D.M. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J. Urol, 2005, vol. 174, no. 5, pp. 1972–1975. doi: 10.1097/01.ju.0000176800.00994.3a.
27. Metzger M.L., Dome J.S. Current therapy for Wilms' tumor. Oncologist, 2005, vol. 10, no. 10, pp. 815–826. doi: 10.1634/theoncologist.10-10-815.
28. Wang J., Li M., Tang D., Gu W., Mao J., Shu Q. Current treatment for Wilms tumor: COG and SIOP standards. World J. Pediatr. Surg, 2019, vol. 2, pp. e000038. doi: 10.1136/wjps-2019-000038.
29. Rostovtsev N., Zhukovskaya E., Pasternak A., Kotlyarov A., Mustakimov B. Morphological study of the combined laser and photodynamic effect with radachlorin on the structure of experimental Ehrlich sarcoma. Revista Inclusiones, 2020, vol. 7, spec. nr, pp. 507–524.
30. Sukhova T.E. Comparative assessment of the efficacy of photodynamic therapy of basal cell skin cancer with the intralesional administration of Radachlorin and Fotoditazin. Almanac of Clinical Medicine, 2016, vol. 44, no. 1, pp. 78–87. (In Russ.) doi: 10.18786/2072-0505-2016-44-1-78-87.
31. Filonenko E.V., Serova L.G., Ivanova-Radkevich V.I. Results from phase III clinical trials with radachlorine for photodynamic therapy of pre-cancer and early cancer of cervix. Biomedical Photonics, 2015, vol. 4, no. 3, pp. 36–42. (In Russ.) doi: 10.24931/2413-9432-2015-4-3-36-42.
32. Vashakmadze L.А., Filonenko Е.V., Cheremisov V.V., Khomyakov V.М. Intraoperative photodynamic therapy for nonorgan retroperitoneal tumors. Photodynamic therapy and photodyagnosis, 2013, vol. 2, no. 2, pp. 8–12. (In Russ.)
Review
For citations:
Rostovtsev N.M., Polyakov V.G., Kuzmina N.E., Neizvestnykh E.A., Kuzmina A.V. The effectiveness of intraoperative photodynamic therapy in the complex treatment of stage III and IV nephroblastoma in children. Biomedical Photonics. 2025;14(4):34-42. https://doi.org/10.24931/2413-9432-2025-14-4-34-42
JATS XML


























